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The adaptive immune response meets the needs of the organism to generate effector cells capable of
controlling pathogens but also leads to production of memory cells, whichmediate more effective protection
during rechallenge. In this review, we focus on the generation, maintenance, and function of memory T cells,
with a special emphasis on the increasing evidence for great diversity among functional memory T cell
subsets.Introduction: Do We Have a Definition of Effector
and Memory T Cells?
During a typical immune response to an acute pathogen,
antigen-specific cells are activated, proliferate vigorously, and
expand extensively. This expansion phase yields a large popula-
tion of effector T cells, most of which will die in the subsequent
contraction phase of the response (Figure 1). However, the
expansion phase also yields cells that will eventually form the
memory cell pool—primed cells maintained long term after
immunization. Immune memory indicates a qualitatively and/or
quantitatively distinct immune response upon successive (but
interrupted) exposures to antigen. This leads to an improved
secondary immune response compared to the primary
response—‘‘improved’’ in this context usually means greater in
magnitude, faster, more sensitive to low doses of antigen, and
more effective in the diversity or complexity of secondary effec-
tors (Kaech and Wherry, 2007; Harty and Badovinac, 2008; Wil-
liams and Bevan, 2007).
The memory cell pool is not monolithic but, rather, contains
diverse and pliable populations. Two broad categories of
memory cells are effector-memory (Tem) and central-memory
(Tcm) (being CD62LloCCR7lo and CD62LhiCCR7hi, respectively)
(Sallusto et al., 1999). This characterization, together with earlier
studies, suggests that phenotypically defined subsets pos-
sessed distinct functional properties (Sallusto et al., 1999)
(Hamann et al., 1997), but subsequent work has only added to
the range of phenotypic and functional memory subsets that
can be identified. So, are there features we can use to clearly
define memory cells (and their subsets) and distinguish these
from effector cells? A minimal definition of memory cells would
be the population that persists long term after antigen clearance
(whereas ‘‘typical’’ effector cells do not). However, there is no
consensus on the minimum longevity sufficient to classify as
‘‘memory,’’ and this definition includes no functional properties.
A commonly used additional criterion is the ability of ‘‘typical’’
memory (but not effector) cells to undergo recall proliferation
and differentiation into secondary effector and memory popula-
tions. Use of these two parameters (longevity and proliferative
potential) allows demarcation of idealized naive, effector, Tem,
and Tcm cell populations (Figure 2A). Tem cells are generallyconsidered to have a more limited lifespan and weaker
proliferative potential compared to their Tcm cell counterparts.
However, analysis of actual postactivation populations illus-
trates much greater diversity in survival and recall potentials
(Figure 2B), as well as diverse subsets defined by other pheno-
typic and functional markers in lymphoid and nonlymphoid sites
(see, e.g., Hikono et al., 2007; Masopust et al., 2006b). Some
cells represented in Figure 2B arise in certain tissue sites or
distinct stages of the immune response, but this chart helps illus-
trate that memory subsets, as well as the properties of ‘‘effector’’
and ‘‘memory’’ cells, are not sharply distinct. Nor will one pair of
criteria accurately define the populations potentially generated
in an immune response: a different chart (with just as much
diversity) could be produced plotting other combinations of
features, such as cytolytic activity versus longevity for CD8+
T cell populations. Without appreciating the diversity of the
postactivation T cell pool, we may miss critical elements in the
armaments induced during adaptive immunity. Our goal here is
to discuss how different populations of postactivation T cells
are generated and how this diverse pool may all contribute to
distinct aspects of recall immune responses and (a distinct
feature) protective immunity. This review will focus exclusively
on T cells and, because of space constraints, will focus mainly
on findings from acute antigen exposure models. The effects
of chronic and persistent infections on T cell memory have
been discussed in recent reviews (Harty and Badovinac, 2008;
Kaech and Wherry, 2007; Williams and Bevan, 2007).
The Choice between ‘‘Effector’’ and ‘‘Memory’’
Differentiation: One Cell to Yield Them All?
Activation of T cells generates a pool with potential to enter the
effector or the memory cell population. A key question intensely
investigated in recent years is what influences the effector
versus memory decision. The simplest model of all would be
that effector cells and memory cells differentiate from distinct
subsets of naive T cells. However, elegant studies demonstrate
that adoptively transferred single naive CD8+ T cells can give
rise to both effector and diverse memory populations (Stem-
berger et al., 2007), a result reinforced by an alternative innova-
tive method of ‘‘cellular barcoding’’ (Schepers et al., 2008)Immunity 31, December 18, 2009 ª2009 Elsevier Inc. 859
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Figure 1. Making Lasting Memories
The schematic showsnumbers of antigen-specific
T cells (black line) at various stages after priming
and boosting of a prototypical acute immune
response. During the primary response, the fate
of typical effector (red line) and memory (green
line) cells is shown. Also shown are populations
of intermediate longevity whom may also con-
tribute to protection form reinfection (maroon
and gold lines).
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necessity, utilized T cell receptor (TCR) transgenic T cells, so it
is unclear whether these results will always be generalizable.
Indeed, recent reports argue that suboptimal TCR stimulation
can lead to T cell elimination after the effector phase (Teixeiro
et al., 2009; Williams et al., 2008), suggesting that there may
be instances where individual clones contribute to the effector,
but not memory, pools (and, potentially, the reverse).
An extension of the ‘‘one cell, multiple fates’’ model has been
proposed by Reiner’s group, based on their studies of asym-
metric cell division during the initial T cell response (Chang
et al., 2007). This report found differential segregation of recep-
tors and signalingmolecules between the first two daughter cells
of activated naive T cells and suggested they may differ in their
capacity to produce effector versus memory pools (Figure 3).
At its most extreme, this model would indicate the fate of
the effector versus memory ‘‘lineages’’ is sealed early in the
response, driven by differential gene expression programs. In
contrast to this strict model, recent work argues gene expression
of ‘‘effector-like’’ molecules (such as Granzyme B in CD8+ T cells
and IFN-g in CD4+ T cells) in cells that later join the memory pool
(as well as in effector cells) (Bannard et al., 2009; Harrington
et al., 2008; Lohning et al., 2008; Maris et al., 2003). These and
other reports fit best with a form of linear differentiation model
in which activated T cells all pass through an ‘‘early effector’’
phase, during which genes for several effector molecules are
expressed. However, this does not exclude the possibility that
cells produced by the first few divisions have different capacities
to join the effector versus memory pool later on (Figure 3). In
addition, however, ‘‘environmental’’ cues such as inflammatory
cytokines can dramatically affect subsequent differentiation of
the activated T cell population (Figure 3), as will be discussed
next.860 Immunity 31, December 18, 2009 ª2009 Elsevier Inc.Everything in Moderation: Better
Memory by Avoiding Overexertion?
A key question is when competent
memory T cell precursors emerge after
activation of naive T cells. Studies on
CD8+ T cells well before the peak of
expansion after primary acute LCMV
infection suggest low expression of the
molecule KLRG-1 identifies cells contain-
ing the memory precursor pool (Sarkar
et al., 2008). Although the reliability of
KLRG-1 expression as a memory precur-
sor marker in other infection models is
unclear, this approach has been usefulto study memory cell generation in the LCMV system. As early
as 4.5 days after primary LCMV infection, some KLRG-1lo cells
have already reacquired the ability to make interleukin-2 (IL-2)
and go on to show enhanced survival and recall proliferation
potential (Sarkar et al., 2008). These cells also show enhanced
ability to subsequently upregulate IL-7Ra, which is important
for memory T cell survival (Buentke et al., 2006; Kaech et al.,
2003; Schluns et al., 2000) and to differentiate into a long-lived
pool of Tcm cells. So what conditions favor generation and/or
survival of memory precursors? Current models suggest a deli-
cate balance between sufficient, but not overexuberant,
responses to various stimuli is the key to good memory.
An appealing model for effector versus memory choice builds
around the idea that sustained stimulatory signals drive cells
into a short-lived effector pool, whereas more transient (but
sufficient) signals favor generation of memory cells (Intlekofer
et al., 2006; Kaech et al., 2002; Lanzavecchia and Sallusto,
2002). The signals discussed here include TCR encounter with
peptide-MHC but also the integration of stimuli through various
adhesion, costimulatory, and cytokine receptors.
Studies in which the intensity of inflammatory cues is con-
trolled suggest restrained exposure to inflammatory cytokines
enhances generation of memory-like cells (Haring et al., 2006;
Kaech and Wherry, 2007). Inflammatory cytokines, such as
type I interferon (IFN-I) and IL-12, operate as ‘‘signal 3’’ (with
TCR and costimulation) to promote CD8+ T cell effector differen-
tiation (Mescher et al., 2006). Studies suggest intense and/or
sustained exposure to IL-12 preferentially promotes CD8+ T cell
differentiation toward the effector rather thanmemory fate (Joshi
et al., 2007; Pearce and Shen, 2007). Other inflammatory cues
probably work indirectly rather than on the T cell itself, and the
impact of cytokine deficiencies can be complex. An instructive
example is IFN-g, deficiency of which leads to a substantial block
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Figure 2. Embracing Diversity
(A) The chart shows the relative longevity and recall expansion potential of ‘‘idealized’’ naive, effector, Tcm, and Tem cell populations, as they are typically dis-
cussed, as well as conflicting models of lineage differentiation.
(B) The same chart is shown with inclusion of some populations found during actual immune responses. The shaded area indicates a distribution ‘‘cloud’’ of cells
with effector-through-memory-like properties. Many populations in this cloud would typically be designated ‘‘Tem,’’ but as indicated, there is also diversity
among the ‘‘Tcm’’ cell pool. Shown are memory populations identified in various tissue sites, including Tem cells from lung bronchoalveolar lavage (BAL) (Ely
et al., 2003) and small intestine (SI) (Masopust et al., 2006b) and Tem and Tcm cells isolated from spleen at different memory time points (‘‘Early’’ and ‘‘Late’’
Tcm and Tem) (Roberts et al., 2005). Also shown are CD8+ T cells primed without sufficient CD4+ T cell help (‘‘Helpless’’), memory-like cells made through lym-
phopenia-driven homeostatic proliferation (‘‘HP’’ memory cells), T cells driven to ‘‘exhaustion’’ by chronic antigen exposure (‘‘Tex’’), and effector cells maintained
into the long-lived phase (‘‘Persistent effector’’). The position of CD8+memory T cells produced in IL-15- (or IL-15Ra-) deficient mice, and of CD25-deficient CD8+
memory T cells is also illustrated, though it is not yet clear whether such cells are representative of populations generated in natural responses (hence, these cells
fall outside the ‘‘cloud’’). Relative positions of populations are not intended to be precise but merely to indicate the diversity of groups identified using only these
two parameters. The box indicates further layers of complexity would be revealed if additional functional parameters (some of which are listed here) were included
in the subset definitions.
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effects of deficiency of IFN-g receptor selectively on responding
CD8+ T cells suggests the cytokine offers a competitive advan-
tage for memory T cell generation in at least some responses
(Whitmire et al., 2007).
How changes in the intensity and/or duration of stimuli change
the balance of effector versusmemory differentiation is still being
discerned. However, evidence points to a key role for differential
expression of the transcription factor T-bet, well known for
supporting ‘‘Type-1’’ T cell differentiation (Glimcher, 2007).
Increasing T-bet expression in activated CD8+ T cells drives
differentiation away from memory-like and toward effector-like
cells, and T-bet is efficiently induced by stimuli, such as IL-12,
which promote effector production (Joshi et al., 2007; Pearce
and Shen, 2007). Furthermore, recent reports suggest that the
transcription factor Blimp-1 is critical for generating mature
effector cells (Kallies et al., 2009; Rutishauser et al., 2009). Stim-
ulated Blimp-1-deficient T cells preferentially differentiated into
central memory-like cells, curtailing the production of effector
cells, a situation that was associated with more efficient immune
control of some pathogens (Rutishauser et al., 2009), but not
others (Kallies et al., 2009). In B cell differentiation, Blimp-1 and
Bcl-6 show mutually antagonistic roles (Calame, 2006), and this
may parallel the situation in T cells because Bcl-6-deficient mice
exhibit defects in the memory CD8+ T cell pool (Ichii et al., 2002).For CD8+ T cells, there is evidence that terminating antigen
encounter (‘‘early leavers’’ in the response) enhances production
of memory precursors (Sarkar et al., 2008). Cells that enter the
response late (‘‘late comers’’) may also have some advantages
in differentiation into the memory pool (Catron et al., 2006;
D’Souza and Hedrick, 2006; van Faassen et al., 2005).
Studies show that at least some perception of inflammatory
cues is required for memory cell differentiation. CD8+ T cells
completely lacking exposure to signal 3 cytokines or deficient
for T-bet showed impaired generation of long-lived functional
memory cells, and T-bet is required for normal expression of
CD122 (the beta-chain of the IL-2 and IL-15 receptors) and reac-
tivity to the homeostatic cytokine IL-15 (Intlekofer et al., 2005;
Joshi et al., 2007; Shaulov and Murali-Krishna, 2008; Xiao
et al., 2009). Indeed, in vitro studies indicate exposure to IL-12
early during T cell priming leads to effective generation of
memory CD8+ T cells (Xiao et al., 2009). Also, it is important to
note that in several studies where inflammatory cues are shown
to promote effector T cell generation, this did not occur at
the expense of generating memory cells, suggesting that the
memory differentiation pathway can progress in the face of
varied production of effector cells (Cui et al., 2009; Joshi et al.,
2007). Prematurely truncating exposure to peptide-MHC ligands
may lead to a failure in memory (and also effector) differentiation
(Figure 3). Activation of CD8+ T cells for only a few hours leadsImmunity 31, December 18, 2009 ª2009 Elsevier Inc. 861
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Figure 3. Walking the Tightrope: Factors Affecting Differentiation of Activated T Cells
After stimulation of naive T cells by antigen-bearing APC, the first cell division is asymmetric and may produce cells with distinct potential to become effector or
memory cells (indicated by shading of daughter cells). However, the products of initial stages of the expansion phase (‘‘Early effectors’’) probably all express key
effector molecules (including Granzyme B in CD8+ T cells and IFN-g in CD8+ T and Th1 cells), yet lack later effector markers (e.g., KLRG-1 for CD8+ T cells). This
early effector pool may have full or only limited potential to become any of the differentiated populations shown on the right. Superimposed on any inherent bias,
the production of effector and memory populations during the remainder of the expansion phase is also conditioned by the duration and intensity of various
signals. These include signaling associated with the TCR and also cytokine receptors. Such signals may dictate expression of key transcription factors including
T-bet and Blimp-1 and also control themetabolic status of the activated cell (including that regulated bymTOR activity). Unusually strong or persistent stimuli may
generate ‘‘exhausted’’ T cells, whereas inadequate stimuli produces ‘‘unfit’’ cells. In between these extremes, effector and memory differentiation may be driven
by cumulative cues operating on the early effector cell (or by selectively favoring outgrowth/survival of cells with a bias toward the effector or memory fate).
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et al., 2003; van Stipdonk et al., 2003; Williams and Bevan,
2004), and shortened encounters with dendritic cells (DCs)
(due to blocked ICAM-LFA interactions) produce a similar effect
(Scholer et al., 2008). Studies with CD4+ T cells also show that
suboptimal and/or short-term stimulation leads to production
of functionally compromised effector cells and minimal memory
generation (Blair and Lefrancois, 2007; Gett et al., 2003; Williams
and Bevan, 2004; Williams et al., 2008). At the other extreme,
overstimulation of activated T cells (e.g., during chronic infection)
can provoke an ‘‘exhausted’’ state, also manifest as impaired
function and maintenance (Kaech and Wherry, 2007).
Together, these studies would argue that there is a Goldilocks
‘‘just right’’ point in which response to TCR cues and inflamma-
tory cytokines (and potentially other cues) supports memory
differentiation without pushing the cells too hard into the short
lived effector pool (Figure 3). But what does ‘‘pushing too hard’’
mean in molecular terms? Quantitative differences in expression
of key transcription factors (e.g., T-bet and Blimp-1, discussed
above) may dictate effector versus memory gene expression
patterns. In addition, recent reports suggest control of T cell
metabolism is important for differentiation toward the long-lived
memory pool. T cells need to switch from the anabolic meta-
bolism characteristic of effector cells to adopt the catabolic
metabolism of quiescent memory (and naive) T cells (Jones and
Thompson, 2007). Two recent reports show that memory CD8+
T cells fail to form if this metabolic switch is prevented (Araki
et al., 2009; Pearce et al., 2009). Regulating the molecule
mTOR is key in this metabolic change, as illustrated by the
capacity of the mTOR inhibitor rapamycin (or knockdown of862 Immunity 31, December 18, 2009 ª2009 Elsevier Inc.components in the mTORC1 complex) favoring emergence of
memory CD8+ T cells from the effector pool (Araki et al., 2009;
Pearce et al., 2009), and a related pathway controlling fatty acid
oxidation is also implicated in the metabolic switch (Pearce
et al., 2009). Once again, however, this regulation is a balancing
act, as complete blockade of mTOR prevents initial T cell activa-
tion and expansion. Such results beg the question of why some
cells in the normal response are successful at making the
required metabolic switch to differentiate from the effector
pool, whereas most cells are not. Via phosphoinositide-3 kinase
(PI3K), mTOR is activated through activation of the TCR and
costimulatory ligands and by various cytokine receptors that, as
we have seen, can modulate the effector and memory cell differ-
entiation. Further, in vitro assays show that culture of activated
CD8+ T cells with IL-2 sustains an effector phenotype, whereas
IL-15 promotes Tcm cell-like differentiation (Manjunath et al.,
2001; Weninger et al., 2001), these differences being mediated,
at least in part, by the intensity of PI3K and mTOR stimulation
(Sinclair et al., 2008). Moderation of stimulatory cues may, there-
fore, be important for promoting the metabolic switch (as well as
other effects) favoring development of the memory pool.
Whether the same rules apply to boostedmemory populations
is much less clear. Markers such as KLRG-1 and effector mole-
cules suchGranzymeB are strongly expressed by cells that seed
the secondary (and tertiary) memory pools, and these very stable
populations very slowly, if at all, acquire a Tcm cell phenotype
(Jabbari and Harty, 2006; Masopust et al., 2006a; Vezys et al.,
2009). Because most vaccines are boosted (as, probably, most
natural infections are reencountered), these data highlight an
important gap in our knowledge of normal memory cell pools.
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effector versus memory cell generation do so by causing altered
differentiation of a uniformly pliable precursor pool or whether
these stimuli promote expansion or survival of more committed
precursors within the activated population (Figure 3). Resolving
such questions, which have been carefully discussed in previous
reviews (Harty and Badovinac, 2008; Kaech and Wherry, 2007;
Williams and Bevan, 2007), will require further analysis of the
differentiation potential of T cells generated early in the immune
response.
The Contraction Phase: Making Life and Death
Decisions
During contraction, short-lived cells are eliminated from the
antigen-specific population. What is the basis for survival of
some cells and death of others? It has become clear that
the death pathway during contraction involves a prominent role
for the proapoptotic factor Bim. Activity of Bim is normally
restrained by Bcl-2 (and related molecules), but downregulation
of Bcl-2 during activation leaves effector cells vulnerable. T cells
lacking Bim undergo relatively normal expansion, but are more
resistant to contraction than their wild-type counterparts (Hilde-
man et al., 2002; Hughes et al., 2008; Prlic and Bevan, 2008;
Weant et al., 2008). The transcriptional regulator Id2 has an
important role in preserving cells through the expansion phase,
as Id2-deficient effector CD8+ T cells show increased cell death,
accompanied by elevated Bim and reduced Bcl-2 expression
(Cannarile et al., 2006)
But what makes short-lived cells susceptible to activating
apoptotic pathways, whereas other cells emerge unscathed?
An initially attractive candidate would be signals from homeo-
static cytokines such as IL-7. Expression of IL-7Ra (CD127) is
downregulated on activated T cells but is re-expressed on a pop-
ulation of cells late in the expansion phase, which correlates with
the KLRG-1lo pool (Joshi et al., 2007; Kaech et al., 2003). IL-7 is
important for maintenance of the memory pool, and (as dis-
cussed above) cues that favor memory T cell generation drive
re-expression of CD127. Furthermore, IL-7 (as well as other gc
cytokines) induces expression of Bcl-2, which restrains Bim
activity. However, several studies have shown that CD8+ T cell
contraction occurs even in priming situations in which the
majority of cells at the expansion peak express IL-7Ra (Lacombe
et al., 2005) and also that enforced (transgenic) expression of
IL-7Ra does not rescue activated cells into the long-lived pool
(Hand et al., 2007; Haring et al., 2008). Hence, CD127 expression
and reactivity to IL-7 is likely necessary, but not sufficient, to
drive the effector to memory cell transition. Along similar lines,
some priming conditions (e.g., DC vaccines) can very rapidly
generate cells which exhibit memory properties (including
KLRG-1loCD127hi phenotype and recall functional potential),
yet these cells contract to a similar extent as cells primed by
conventional pathways (Badovinac et al., 2005).
So, are there priming situationswhere contraction is averted or
minimized? Very short-term pathogen infection can lead to
priming of a CD8+ T cell response, which is modest in size but
very effectively undergoes transition to a functional memory
pool (Badovinac et al., 2004). The idea that this outcome is (at
least in part) due to moderating inflammatory stimuli is further
supported by the similar phenotype in IFN-g-deficient animals(Badovinac et al., 2000) (Harty and Badovinac, 2008). Further-
more, there is generally less contraction after secondary
responses (Badovinac et al., 2003; Masopust et al., 2001a),
and this effect is even more dramatic after tertiary stimulation
(Masopust et al., 2006a; Vezys et al., 2009). Such findings might
be related to more rapid elimination of antigen and reduced
intensity or duration of inflammatory cytokines, such as IFN-g,
due to the high frequency of antigen-reactive cells. Interestingly,
the phenotype of the durable memory cells from boosting is
similar to effector memory or even effector cells (Jabbari and
Harty, 2006; Masopust et al., 2006a, 2006b), which contrasts
with models in which differentiation to Tcm cell phenotype
predicts optimal longevity.
What about the opposite situation: priming situations which
lead to more extensive contraction? As discussed earlier, insuf-
ficient duration or quality of TCR and other stimuli can yield
effector cells that contract without leaving a memory pool. For
the CD4+ T cell pool, this is also seen in situations of excessive
competition with naive cells of the same specificity (Blair and
Lefrancois, 2007; Hataye et al., 2006; Whitmire et al., 2008).
Strangely enough, for CD8+ T cells, abnormally high naive
T cell precursor frequencies and short-term antigen exposure
seem to accelerate, rather than block, production of functional
memory cells without augmenting contraction (Badovinac
et al., 2007). The basis for these interesting differences between
CD4+ and CD8+ T cells is unclear but highlights the risks of inter-
preting studies using antigen-specific naive T cells at non-phys-
iologically high frequencies.
The Issue of ‘‘Not-So-Short-Lived’’ Effectors
Despite the substantial decline in antigen-specific effector T cells
during contraction, some cells with this phenotype are found
a considerable time after clearance of antigen (many months
in the spleen, and even longer in other tissue sites—see later).
Further, adoptive transfer approaches show that effector-like
cells actually have a fairly leisurely decay rate. For example,
T cells isolated from the expansion phase as ‘‘effector’’ versus
‘‘memory precursor’’ pools (using markers such as IL-7Ra or
KLRG-1) differ only slightly (3-fold) in their persistence at
4–6 weeks (Kaech et al., 2003; Sarkar et al., 2008), despite the
fact that the effector pool exhibits minimal basal homeostatic
proliferation. The continued survival of these effector-phenotype
cells is not simply due to them differentiating into memory cells,
because themajority of transferred KLRG-1hiIL-7Ralo cells main-
tain this phenotype for many weeks after adoptive transfer
(Sarkar et al., 2008). Likewise, studies on Sendai-infected mice
suggest CD8+ T cells with effector-like properties (including
sustained expression of Granzyme B expression) persist for
many months after infection (Hikono et al., 2007).
A more extreme situation is where repeated immunizations
have been used to boost the memory T cell pool and for popu-
lations in nonlymphoid sites. Compared to primary immune
responses, the boosted CD8+ T cell population sustains a popu-
lation of cells with more effector-like properties (Granzyme
B+KLRG-1hi and, in some cases, IL-7Rlo), suggesting such cells
are not always short lived (Jabbari and Harty, 2006; Masopust
et al., 2006a; 2006b).
This finding leads to the important question of whether such
‘‘not-so-short-lived’’ effector cells have any functional relevanceImmunity 31, December 18, 2009 ª2009 Elsevier Inc. 863
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Reviewor are purely detritus waiting to be cleared from tissues. We
will return to this question when we discuss the function of the
long-lived pool later.
Maintenance and Distribution of the Long-Lived Pool:
The Persistence of Memory Cells
The typical view of a ‘‘useful’’ primed cell is one which is both
long-lived (at the population level) and displays the functional
traits of a memory cell (including the ability to undergo recall
proliferation and differentiation into secondary effector and
memory cells). A long-standing controversy regarded whether
T cell memory maintenance depended on constitutive stimula-
tion by cognate antigen. Resolution of this argument had impli-
cations for whether vaccines should provide persistent depots
of antigen or require periodic boosting. In contrast to naive
T cells, memory CD8+ and CD4+ T cells are maintained in the
absence of MHC molecules (Freitas and Rocha, 2000; Murali-
Krishna et al., 1999; Swain et al., 1999). Memory CD8+ T cells
appear to maintain both self-renewal and function in the
complete absence of MHC I (Leignadier et al., 2008; Murali-
Krishna et al., 1999); however, optimum memory CD4+ T cell
function may depend on exposure to MHC II (De Riva et al.,
2007; Kassiotis et al., 2002). Most recently, it was elegantly
demonstrated that ablation of TCR also had no effect onmemory
CD8+ T cell survival (Leignadier et al., 2008). However, chronic
infections can markedly alter T cell survival requirements, result-
ing in cells that are ‘‘addicted’’ to antigen andwane upon transfer
to naive hosts (Shin et al., 2007).
After clearance of acute infections, memory CD4+ and CD8+
T cell maintenance depends on IL-7 and IL-15, which together
support survival and basal homeostatic proliferation of the pool
(for a recent comprehensive review of this interesting topic,
see Surh and Sprent, 2008). Competition for these homeostatic
cytokine resources may define a limited carrying capacity of the
immune system for memory T cells. Such a mechanism may
ensure that exposure to numerous infections throughout life
does not result in an ever increasing expansion in the size of
memory T cell compartment with age.
Most studies have focused on memory populations sustained
in secondary lymphoid organs (SLOs) and parenchymal sites,
but recent evidence suggests memory CD4+ and CD8+ T cells
may make a primary home in the bone marrow (Becker et al.,
2005; Mazo et al., 2005; Tokoyoda et al., 2009). This notion
creates an interesting anatomic separation issue in the response
to nonsystemic recall antigen, suggesting an obligation by
antigen-presenting cells to find the bone marrow-resident
memory cells or egress of the memory T cell population to
access SLOs or nonlymphoid sites.
It should be noted that Tem cells may express lower amounts
of CD122 and undergo less homeostatic proliferation than Tcm
cells, which may account for the relatively short life span of
Tem cells within blood observed after certain primary infections
(Jabbari and Harty, 2006; Wherry et al., 2003). However, heterol-
ogous prime-boost vaccination can result in a 4-fold expansion
of the Tem cell pool outside of lymph nodes, with little evidence
for a reciprocal reduction among the Tcm cell compartment
(Vezys et al., 2009). In the absence of further infection, this
compartment appears stable, suggesting the size of the Tem
cell compartment is not subject to stringent regulation and864 Immunity 31, December 18, 2009 ª2009 Elsevier Inc.may depend on different factors for survival than those defined
for Tcm cells. Indeed, in humans, CD45RA+ Tem cells gradually
accumulate with age (Czesnikiewicz-Guzik et al., 2008). This
process may occur in the absence of cytomegalovirus (CMV)
infection and may be distinct from the memory-like T cell clonal
expansions observed among the very old (Clambey et al., 2008;
Ely et al., 2007; Messaoudi et al., 2006).
The durability of T cell memory remains unclear. In mice, infec-
tion with lymphocytic choriomeningitis virus (LCMV) results in
a stable memory CD8+ T cell pool for >900 days, whereas
memory CD4+ T cells reduced to 1/50 of the original number
over the same period (Homann et al., 2001). Although human
memory T cell longevity studies are in their infancy (due to their
greater logistical complications), a few important studies have
examined this issue in situations where periodic pathogen
re-exposure is unlikely. Fairly robust numbers of memory CD8+
T cells were detected >15 years after infection with Puumala
virus (PUUV) without evidence for viral persistence or reinfection
(Van Epps et al., 2002). Up to 1% of CD8+ and CD4+ T cells
remained specific for measles virus among adults that had
a history of natural childhood infection (Nanan et al., 2000). The
most comprehensive study to date recounts a nonrandomized,
cross-sectional analysis of CD4+ and CD8+ T cell memory per-
formed between 1 month and 75 years after smallpox vaccina-
tion (Hammarlund et al., 2003). Virus-specific memory T cells
were detectable up to 75 years after a single vaccination, with
an estimated half-life between 8 and 15 years among both
CD8+ and CD4+ T cells. However, it should be noted that long-
lived CD8+ T cell immunity was not detected in all individuals,
although the reasons for this are unclear.
Although these observations support the hypothesis that T cell
memory may persist for the life of the host, it has been shown
that certain heterologous infections can result in the ablation of
pre-existing memory CD8+ T cells. This process is unlikely to
be explained by direct competition between memory cells as
the extent of attrition was severe (25%–90%) and attrition was
induced within only a few days of infection via a Type I or II
interferon-dependent process (Dudani et al., 2008; Selin et al.,
1999). It will be important to determine how natural infections,
as well as immunization, impact the pre-existing memory T cell
pool in humans. Although information remains limited, a recent
study failed to detect an impact on the number of blood-born
influenza- and EBV-specific CD8+ T cells upon primary human
cytomegalovirus (HCMV) infection (van Leeuwen et al., 2006).
Although more studies are needed, available data suggest that
T cell memory in humans is generally long-lived but perhaps
not as durable as humoral immunity, which has estimated half-
lives that may exceed 50 years (Amanna et al., 2007; Crotty
et al., 2003). However, it should be stressed that these data
are derived from individuals whom were exposed to live repli-
cating agents. It is possible that certain immunizations may fail
to produce truly long-lived memory T cells (see below).
Non-Lymphoid Tissues and the Related Concept
of Effector Memory: Getting There
Activation within SLOs precipitates changes in homing molecule
expression that results in the anatomic redistribution of antigen-
specific T cells. Changes in migration potential are likely regu-
lated both by the strength of stimulation, reflected by the
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and the inflammatory milieu, and also by location specific cues
that vary within different SLO environments.
In situations where strength of stimulation is likely reduced,
either via high-dose adoptive transfer of transgenic CD8+
T cells or by spiking in naive T cells a few days after the initiation
of infection (artificially introducing ‘‘late comers’’), a much higher
proportion of memory T cells express lymph node homing mole-
cules (Catron et al., 2006; D’Souza and Hedrick, 2006; Sarkar
et al., 2007; van Faassen et al., 2005). Similarly, CD4+ T cells
within the lung were found to have undergone a larger number
of divisions than their counterparts within lymph nodes (Roman
et al., 2002). Interestingly, ‘‘strength of stimulation’’ may be
cumulative because boosting memory CD8+ T cells via repeated
infection results in the preferential accumulation of CD62L cells
that populate nonlymphoid organs (Jabbari and Harty, 2006;
Masopust et al., 2006a).
Location-specific cues have been best defined within SLOs
associated with the intestinal mucosa and the skin (Agace,
2006;Mora et al., 2008; Sigmundsdottir andButcher, 2008). After
activation within Peyer’s patches and mesenteric lymph nodes,
activated T cells preferentially upregulate receptors involved
in homing to the small intestine. This instructional program is
dictated in part by CD103+ DCs and the local availability of
retinoicacid. In contrast, T cells primedwithin the skin-associated
inguinal lymph nodes preferentially upregulate skin homing
receptors, a process intriguingly promoted by local higher
concentrations of Vitamin D3 metabolites. Although priming
within local SLO environments thus favors T cell trafficking to
regionally associated nonlymphoid tissues, it should be stressed
that there are several examples in which local immunization
routes result in widely disseminated T cell responses within all
tissues examined (Kaufman et al., 2008; Liu et al., 2006; Maso-
pust et al., 2004). It remains possible that promiscuous seeding
of numerous nonlymphoid compartments is dependent on
immunization regimens that induce strong ‘‘strength of signal’’
priming, as induced by live replicating agents, and that subunit
vaccines may result in responses that remain preferentially
distributed within lymph nodes and local tissues.
Nonlymphoid Tissues: Upon Arrival
After clearance of infection, large numbers of T cells remain
distributed within nonlymphoid tissues (Masopust et al., 2001b;
Reinhardt et al., 2001). Confirming predictions based on anal-
yses of human blood T cells that lacked lymph node homing
receptors (Sallusto et al., 1999), T cells isolated from tissues
differed from ‘‘classic’’ memory T cells in many important func-
tional respects. This precipitated the paradigm that long-lived
(i.e., ‘‘memory’’) T cells should be divided into two subsets:
Tcm cells, which exhibit classic memory T cell properties and
traffic through SLOs, and Tem cells, which recirculate through
nonlymphoid tissues (Sallusto et al., 2004).
The generic term ‘‘nonlymphoid tissue’’ accounts for all cells
outside of the major inductive sites of immune responses (e.g.,
lymph nodes and the white pulp of spleen) and does not
discriminate between the varied anatomic compartmentalization
outside of SLOs. For instance, some cells are likely confined to
the vasculature, even among solid organs that have been
perfused to remove the majority of red blood cells. One exampleincludes the liver, in which the vast majority of lymphocytes are
likely confined to the sinusoids rather than being located within
the parenchyma (Geissmann et al., 2005). Some of these cells
may be just quickly passing through, and others may be actively
retained on endothelium as has been recently described for
a subset of monocytes (Auffray et al., 2007). In contrast, memory
T cells are also present within the parenchyma of nonlymphoid
tissues, such as the skin and mucosal tissues. Moreover, there
are populations of nonlymphoid T cells, such as those within
the lung airways, that are localized neither in blood vessels nor
in the tissue parenchyma (Woodland and Kohlmeier, 2009). To
add to this complexity, there are regional specializations in
environments with respect to the cytokine milieu, density of
lymphocytes and other hematopoietic cells, tissue architecture,
and environment. These tissue-specific differences may reflect
exposure tomicrobial products (forexample, thecommensal flora
in the intestinal mucosa) and the ability of each tissue to tolerate
inflammation while maintaining organ function (for instance,
inflammation in the lower lung airways inhibits gas exchange).
Therefore, it is perhaps not surprising that T cell properties
vary considerably among different anatomic locations, and
recent data suggest that the tissue environment plays a direct
role in shaping this process independent of variables associated
with T cell priming within SLOs. For instance, the environment of
the peritoneum in mice induces expression of CD49d among
memory CD4+ T cells (Kassiotis and Stockinger, 2004). The
lung environment also directly modulates memory CD8+ T cell
phenotype (Marzo et al., 2007). For instance, transfer of Tcm
cells into the lung airways via the trachea results in the rapid
adoption of a unique tissue-specific signature phenotype char-
acterized by downregulation of CD27 and CD127 (Kohlmeier
et al., 2007). Cells in the lung airways also downregulate
Ly6C and CD11a, which are typically highly expressed among
antigen-experienced T cells in other tissues. These cells are
not long-lived but must be continually maintained by an influx
of memory T cells from the periphery (Ely et al., 2006). A quite
distinct tissue-specific phenotype is adopted among CD8+
T cells after entry within the epithelium of the small intestine.
These cells adopt several cardinal features of recently activated
T cells, including upregulation of CD69 and the maintenance of
lytic activity indefinitely (Masopust et al., 2006b). Interestingly,
these cells express only low amounts CD122 and undergo rela-
tively little homeostatic division, yet the population can remain
stable without evidence for continued recruitment, suggesting
that they may have unique maintenance requirements (Ma
et al., 2009; Masopust et al., 2006b). Intravenous transfer of
memory T cells from the intestinal epithelium, followed by restim-
ulation, resulted in a secondary response that distributed to
numerous tissues. Those daughter cells that were recovered
from spleen 8 months later had adopted the cardinal features
of classic Tcm cells, further supporting the hypothesis that tissue
environments directly influence T cell differentiation state and
also indicating that a very ‘‘effector-like’’ phenotype is not
terminal (Masopust et al., 2006b). Although we only cited a few
examples, it appears likely that T cells in many tissues, including
skin and the central nervous system, may adopt tissue-specific
signature phenotypes (Gebhardt et al., 2009; van der Most
et al., 2003). Nonlymphoid memory T cells that are essentially
occupying blood vessels or are rapidly recirculating, such asImmunity 31, December 18, 2009 ª2009 Elsevier Inc. 865
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lung, may be less subject to tissue-derived environmental cues.
In this light, conceptually lumping together all nonlymphoid
sites is not likely to account for the complexity of T cell differen-
tiation states. Experimentally, cells isolated from a single non-
lymphoid tissue are unlikely to represent the properties of Tem
cells in other tissues. This issue is but one reflection of the diffi-
culty in defining Tem cells as a homogenous entity. In fact, in its
current usage, Tem cells reflect a broad array of T cell differenti-
ation states that differ from the classical definition of memory
T cells (Figure 2). These differentiation states are regulated
both by the strength of stimulation during priming, but also by
largely unknown tissue-specific factors. An important issue of
continuing study is whether memory cell survival is equivalent
in all tissue locations (Woodland and Kohlmeier, 2009), although
the challenge will be to assess this in situ. It must also be appre-
ciated that properties of memory T cells may be affected tran-
siently or permanently by local cues. These observations are
not an attempt to muddy the waters but, rather, to confront the
true diversity of T cell qualities and to acknowledge the rather
imprecise meaning of the term Tem cells. One current challenge
is to determine more completely how T cell differentiation states
are regulated, how they are coupled with T cell trafficking, and
how these issues relate to protective immunity (see below).
T Cell Protective Immunity: A Matter of Quality,
Quantity, Time, and Location
This review has recounted numerous studies that have attemp-
ted to penetrate the processes by which memory T cells are
made and the factors that govern their maintenance, anatomic
distribution, and functional potential. An overarching raison
d’eˆtre of all these studies is to determine how to exploit this
knowledge for the development of safe, effective vaccines.
Achieving this ultimate goal will require a thorough under-
standing of the parameters that relate to protection.
For a memory T cell to participate in protection, it must still be
present upon reinfection. As discussed above, certain subsets of
antigen-specific T cells wane at a leisurely rate after clearance of
infection. However, does this mean that these short-livedmemo-
ries (or long-lived effectors) are useless by-products of an
immune response, or do they confer a transient state of height-
ened host protection? In a mouse model of LCMV infection,
CD62LCD8+ T cells gradually decay or convert to central
memory T cells (Wherry et al., 2003). Although these cells were
somewhat impaired in their ability to undergo proliferation
upon restimulation, they were able to confer protection upon
transfer to secondary recipients. Amorenatural, albeit anecdotal,
example comes fromamousemodel of heterosubtypic immunity
(Liang et al., 1994).Micewere infectedwith influenza virus, result-
ing in long-lived memory in most tissues. As described above,
short-lived T cells persist in the lung airways, but maintenance
of this population depends on continued recruitment from the
periphery. For reasons unknown, this recruitment abates over
time, resulting in the presence of a very small population of
antigen-specific CD8+ T cells by 6 months after infection. Ger-
hard and colleagues found that protective immunity against a
serotypically distinct influenza virus (against which T cells
mediate protection) waned with kinetics similar to the attrition
of the memory population in the lung airways (Liang et al., 1994).866 Immunity 31, December 18, 2009 ª2009 Elsevier Inc.This finding suggests that short-lived T cells within the lung
airways provide short-lived protection and also supports the
appealing notion that T cells positioned at the point of pathogen
entry may play an important role in protective immunity against
certain infections. Woodland and colleagues revisited this issue
more directly by transferring Sendai virus-specific T cells from
the lung airways of immune mice into the airways of naive mice
(Hogan et al., 2001). In this model, they showed that CD4+
T cells conferred some degree of protection upon homologous
challenge. Similar findings were recently reported in an elegant
model of herpes simplex viral challenge, demonstrating a role
for skin-resident CD8+ T cells in mediating rapid protection at
the site of infection (Gebhardt et al., 2009). These studies
support concerted efforts to establish site-specific T cell immu-
nity through vaccination in the hopes of contributing to rapid
containment of pathogens such as HIV. However, defining the
role that T cells positioned outside of SLOs play in protective
immunity remains a major challenge.
Delineation of memory T cells into Tcm and Tem cell subsets
has attracted substantial interest among vaccinologists in the
hopes that creation of the right ‘‘kind’’ of memory T cells might
provide the key to protection. In turn, so-called Tcm and Tem
cells have been compared in various protection models, with
conflicting results, depending on the experimental system. It
should be noted that Tcm cells are often generated by different
methods among different studies (for example, live viral infec-
tions versus heat killed Listeria monocytogenes, LM) and delin-
eated solely by the expression of markers such as CD127 and
CD62L. Such a read-out does not account for variables in the
function of Tcm cells after different priming regimens (e.g.,
whether they rapidly produce IFN-g upon restimulation). Similar
concerns regard comparisons of Tem cells among different
studies, highlighting the challenges that imprecise definitions
of T cell subsets pose to the field. With these substantial caveats
inmind, it appears that Tem cells aremost effective at controlling
vaccinia virus and LM infections, as measured by evaluating
infectious burden 3 to 4 days after infection (Bachmann et al.,
2005; Huster et al., 2006). In contrast, Tcm cells may be more
effective at controlling a systemic challenge with a strain of
LCMV that causes a chronic infection in naive mice (Wherry
et al., 2003). In the latter study, it should be noted that Tcm cells
did not contribute to protection until more than a week after viral
challenge. In this instance, it seems likely that substantial expan-
sion of the antigen-specific CD8+ T cell population, as well as
differentiation into effector cells, was required before it was
able to contribute to viral control. A tentative conclusion that
could be drawn from these studies is that Tem cells might be
more effective at controlling infections very early, especially
outside of SLOs. However, if the infectious challenge exceeds
the capacity of pre-existing Ag-specific cells to control infection,
then the greater proliferation potential of ‘‘classic’’ memory CD8+
T cells wins the day. Thus, the importance of different subsets
may vary depending on the pathogen in question, the route
and dose of infection, and the quantity of antigen-specific
T cells present prior to infection.
The above discussion raises another important question: how
important is T cell quantity? This question takes on additional
prescience in light of the recent and highly publicized failure of
the Phase 2b AIDS vaccine efficacy ‘‘STEP’’ trial, which
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against HIV in humans. Although this vaccine generated 100–
500 HIV-specific memory CD8+ T cells per 106 peripheral blood
mononuclear cells (PBMCs), it afforded no protection. Was this
a failure of CD8+ T cell quantity, quality, and/or anatomic distri-
bution or, rather, a revelation that CD8+ T cells cannot protect
against HIV (Masopust, 2009)? There is little information to guide
informed speculation. However, recent studies found that higher
frequencies of CD8+ T cells (2000 per 106 PBMC) generated by
prime-boost vaccination or immunization with a persistent
vector afforded some degree of protection against fairly strin-
gent SIV challenges in nonhuman primates (Hansen et al.,
2009; Liu et al., 2009). Although this bolsters hope in the CD8+
T cell vaccine concept, more information is needed regarding
the relationship between CD8+ T cell quantity, quality, and
protective immunity. In this light, a study from Harty and
colleagues carries both good and bad news. Using a creative
model of prime-boost vaccination, they modulated the number
of memory CD8+ T cells specific for Plasmodium (Schmidt
et al., 2008). They found that CD8+ T cell immunity was sufficient
to prevent blood-stage parasitemia, but only if the quantity of
antigen-specific CD8+ T cells exceeded a very large minimum
threshold (>1% of blood lymphocytes). In comparison, 1/100
to 1/1000 of the number of CD8+ T cells was sufficient for protec-
tion against LM or LCMV. Although this study did not rule out
changes in quality induced by the different immunization
schemes that may also have contributed to protection, it illus-
trates that the requirements for CD8+ T cell-mediated protective
immunity against some pathogens may greatly exceed that
generated by current human vaccine strategies that rely heavily
on replication-deficient vectors.
Bad Memories
Just as there are many ways to define a ‘‘good’’ memory cell,
there are also ways these cells can fail to contribute to the recall
response. A well-studied case is CD8+ T memory cells primed in
the absence of CD4+ T cell help. In many acute infection models,
the production of effector and memory CD8+ T cell populations
follows the normal pattern despite CD4+ T cell deficiency. These
‘‘unhelped’’ CD8+ T memory cells show reduced maintenance
but more dramatically show impaired function (including protec-
tion) and an almost complete loss of recall proliferative capacity
(Janssen et al., 2003; Sun and Bevan, 2003; Shedlock and
Shen, 2003). Although the exact basis for these defects is
currently unclear, an unexpected twist is that T-bet deficiency
partially rescues the ‘‘unhelped’’ CD8+ T memory cell phenotype
(Intlekofer et al., 2007). Interestingly, analogous defects in
recall proliferative potential are observed for CD8+ T cells which
lack expression of IL-2Ra (CD25) (Williams et al., 2006), raising
the possibility that CD4+ T cell-produced IL-2 may be an critical
element in CD4+ T cell ‘‘help’’ for CD8+ T cell memory. Thus,
despite the fact that both unhelped and CD25-deficient
(Il2ra/) CD8+ T memory cells resemble Tcm cells, they show
defective homeostasis and/or reactivity (Figure 3).
Functional deficiency may also arise due to suboptimal
priming, and thismay be difficult to observe by simplymonitoring
T cell numbers or individual functional readouts. Testing various
vaccination approaches for priming CD4+ T cell responses to
Leishmainia antigens revealed that protective immunity corre-lated with the cells capacity for multiple functional responses
(Darrah et al., 2007).
Alternative Ways to Make Memory Cells: ‘‘Homeostatic’’
Memory
Are the specificities of T cell memories always restricted to the
pathogens that induced them? Perhaps not. One important
example is the case of heterosubtypic immunity, by which
memory CD8+ T cells mount secondary responses upon chal-
lenge with serologically distinct but phylogenetically related
viruses. Such observations have been made in several models,
including infection of mice with vesicular stomatitis viruses of
the New Jersey and Indiana strains and influenza viruses, which
also confer a degree of protective immunity against the second
challenge (Christensen et al., 2000). In addition, situations have
also been documented in which immunity to one virus, LCMV,
confers protection to an unrelated virus, vaccinia. Interestingly,
the specificity of cross-reactive CD8+ T cell clones between
LCMV and vaccinia virus varies among individual inbred mice,
suggesting that cross-reactivity between different infectious
agents may not be uncommon (Kim et al., 2005). Indeed,
cross-reactive human CD8+ T cell clones have been detected
that recognize epitopes from both influenza A virus and Epstein-
Barr virus (Clute et al., 2005). These observations suggest that
primary responses among individuals with a diverse repertoire
of memory CD8+ T cells may contain reactivated secondary
clonal expansions of rare cross-reactive pre-existing memory
T cells. Such events may influence the quality and immunodomi-
nance hierarchy of the response and may have implications for
protective immunity.
‘‘Homeostatic’’ Memory
Over the last 10 years, it has become clear that the scheme
shown in Figure 1 is not the only means to generate memory
T cells. During studies on T cell homeostasis, it was found that
naive cells respond to T cell lymphopenia by undergoing a
slow proliferation (variously called ‘‘homeostatic proliferation’’
or, less ambiguously, ‘‘lymphopenia induced proliferation,’’ or
LIP), during which time the naive cells change in their phenotype
and function to resemble memory cells (Surh and Sprent, 2008).
This process involves recognition of self peptide-MHC mole-
cules and the cytokines IL-7 and IL-15 (Surh and Sprent,
2008), but cells responding to lymphopenia appear not to
transition through a detectable effector stage. This process
may therefore resemble the low intensity stimuli that promote
memory T cell differentiation discussed earlier. LIP generates
memory cells that exhibit functional properties similar to ‘‘true’’
(i.e., antigen primed) memory cells (Surh and Sprent, 2008) and
are capable of undergoing a strong proliferative response
when stimulated by foreign antigen and mediating protective
immunity against infection (Hamilton et al., 2006). Although typi-
cally studied in artificial situations of lymphopenia, similar
processes may occur in normal physiological stages, such as
during the lymphopenia associated with neonatal mice (Ichii
et al., 2002; Min et al., 2003; Schuler et al., 2004). This raises
the possibility that the endogenous T cell pool may contain
memory-like cells produced without conventional priming.
While an ‘‘endogenous’’ memory T cell pool has long been
documented in mice (including those maintained in SPF orImmunity 31, December 18, 2009 ª2009 Elsevier Inc. 867
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2005), the specificity of this pool was largely unexplored. Recent
studies suggest that the endogenous pool of memory phenotype
cells includes cells with reactivity toward unencountered foreign
antigens (Haluszczak et al., 2009). This normal pool, which has
hallmarks of deriving from LIP, exhibits at least some of the func-
tional traits of memory cells (Haluszczak et al., 2009). However,
this population is extremely rare, representing only a fraction of
the naive antigen-specific precursor pool, and how these cells
contribute to physiological immune responses, andwhether their
contribution differs from that of their naive counterparts, awaits
further studies. However, these findings do suggest unprimed
endogenous memory cells may be active participants in
‘‘primary’’ immune responses.Concluding Remarks
The chief objectives in this review were not only to discuss new
developments in our understanding of the generation and func-
tion of memory T cells, but to highlight the fact that memory
T cell populations are tremendously diverse in terms of pheno-
type, function, developmental plasticity, distribution, longevity,
and protective capacity. A single, or even a handful, of markers
is unlikely to reliably predict either the developmental or protec-
tive potential of ‘‘subsets’’ that transcend single experimental
systems. Ignoring this complexity and splitting T cells into poorly
defined effector and memory subsets, may create disagree-
ments that are more grounded in semantics than biology.
However, a range of innovative techniques, including analyses
of single cells, cellular barcoding, and genome-wide transcrip-
tional profiling, seem poised to push our insight even further
into T cell-fate decisions. When such information is coupled to
bona fide studies of protective immunity, the field has the poten-
tial to make tremendous and much needed contributions to the
development of protective T cell vaccines.
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